MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1186/s12889-023-16401-4

Медицинская библиотека · BMC public health · 2023

Risk analysis of COVID-19 hospitalization and critical care by race and region in the United States: a cohort study.

Jimbo Mitsuki, Saito Sakae, Uematsu Takayuki, Hanaki Hideaki, Otori Katsuya, Shibuya Kiyoshi, Ando Wataru

СтатьяПеревод в очереди

Аннотация

BACKGROUND

This study aimed to identify the current risk factors for coronavirus disease 2019 severity and examine its association with medication use.

METHODS

We used data from a large United States electronic health record database to conduct an anonymized cohort study of 171,491 patients with coronavirus disease 2019. The study was conducted from January 1, 2020, to August 27, 2021. Data on age, race, sex, history of diseases, and history of medication prescriptions were analyzed using the Cox proportional hazards model analysis to calculate hazard ratios for hospitalization and severe risk.

RESULTS

Factors that increased the risk of hospitalization and critical care were age ≥ 65 years, male sex, type 2 diabetes, hypertension, interstitial pneumonia, and cardiovascular disease. In particular, age ≥ 65 years significantly increased the risk of hospitalization (hazard ratio, 2.81 [95% confidence interval, 2.58-3.07]; P < 0.001) and critical care (hazard ratio, 3.45 [2.88-4.14]; P < 0.001). In contrast, patients with hyperlipidemia had a reduced risk. However, patients with hyperlipidemia who were not taking statins had a significantly increased risk of hospitalization (hazard ratio, 1.24 [1.16-1.34]; P < 0.001). Sodium-glucose cotransporter-2 inhibitors, angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, glucocorticoids, and statins significantly reduced the risk of hospitalization and critical care. The risk of hospitalization and critical care increased in patients of all ethnicities with type 2 diabetes. The factors that significantly increased the risk of hospitalization in all regions were older age, hypertension, chronic obstructive pulmonary disease, and cardiovascular disease.

CONCLUSION

This study identified factors that increase or reduce the risk of severe coronavirus disease. The provision of appropriate drug treatment and modification of lifestyle-related risk factors may reduce coronavirus disease severity.

Для цитирования: Jimbo Mitsuki, Saito Sakae, Uematsu Takayuki, Hanaki Hideaki, Otori Katsuya, Shibuya Kiyoshi, Ando Wataru. Risk analysis of COVID-19 hospitalization and critical care by race and region in the United States: a cohort study.. BMC public health. 2023. DOI: 10.1186/s12889-023-16401-4.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.